The Patent Finder

Terms ending in 2032

Abraxis Bioscience, LLC

Every in-force patent on Abraxis Bioscience, LLC's record whose computed term ends in 2032, whoever holds it now. Soonest term end first, then patent number.
PatentTitleHolderStatusExpiresConfidence
US 9,393,318Methods of Treating Cancer
In force
 · High confidence
Abraxis Bioscience, LLCIn forceHigh confidence
US 9,597,409Methods of Treating Cancer
In force
 · High confidence
Abraxis Bioscience, LLCIn forceHigh confidence
US 10,258,565Intravascular Delivery of Nanoparticle Compositions and Uses Thereof
In force
 · Medium confidence
Mercator Medsystems, Inc.In forceMedium confidence
US 9,061,014Intravascular Delivery of Nanoparticle Compositions and Uses Thereof
In force
 · High confidence
Mercator Medsystems, Inc.In forceHigh confidence
US 8,911,786Nanoparticle Comprising Rapamycin and Albumin as Anticancer Agent
In force
 · High confidence
Abraxis Bioscience, LLCIn forceHigh confidence
US 9,585,960Use of Polymeric Excipients for Lyophilization or Freezing of Particles
In force
 · High confidence
Abraxis Bioscience, LLCIn forceHigh confidence
US 10,076,501Use of Polymeric Excipients for Lyophilization or Freezing of Particles
In force
 · Medium confidence
Abraxis Bioscience, LLCIn forceMedium confidence
US 10,555,912Use of Polymeric Excipients for Lyophilization or Freezing of Particles
In force
 · Medium confidence
Abraxis Bioscience, LLCIn forceMedium confidence
8 of 8 patents shown. Soonest term end first, then patent number.
6 of these are in force and held by Abraxis Bioscience, LLC.
Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited